Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function

Sara Paccosi1, Laura Pala2, Barbara Cresci2

  • 1Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.

Insights

Dysfunctional dendritic cells (DCs) in obese, post-menopausal women with type 2 diabetes (T2DM) may increase vascular inflammation. This dysfunction, linked to obesity and diabetes, impacts immune cells crucial for cardiovascular health.

Area of Science:

  • Immunology
  • Endocrinology
  • Cardiovascular Science

Background:

  • Cardiovascular disease (CVD) is common in post-menopausal women, linked to obesity and insulin resistance.
  • Immunological mechanisms, particularly dendritic cells (DCs), play a role in vascular remodeling, but their specific function in this context is unclear.

Purpose of the Study:

  • To characterize monocyte-derived dendritic cells (Mo-DCs) in post-menopausal women with type 2 diabetes (T2DM) and obesity.
  • To investigate Mo-DC function and phenotype in relation to atherosclerosis risk factors.

Main Methods:

  • Phenotypic and functional characterization of Mo-DCs using flow cytometry and mixed lymphocyte reactions.
  • Assessment of mRNA integrin expression and circulating fetuin-A and adiponectin levels.

Main Results:

  • Mo-DCs showed phenotypic dysregulation, defective lymphocyte stimulation, and increased mRNA for adhesion molecules (CD11c, CD18, DC-SIGN/CD209).
  • Altered fetuin-A and adiponectin levels were observed, negatively correlated with each other.
  • Hyperglycemia impaired the conversion of CD14+ cells into Mo-DCs.

Conclusions:

  • Mo-DCs are dysfunctional in obese, post-menopausal women with T2DM, even without clinical CVD.
  • The combination of obesity and diabetes exacerbates Mo-DC dysfunction, potentially increasing vascular inflammation.
Abstract